Source disclosure: February 13, 2026
COSMO BIO COMPANY,LIMITED [3386.T]
TOKYO, Feb 23 (Pulse News Wire) – Cosmo Bio Company,Limited (3386.T) reported consolidated results for fiscal year 2025 ending December. 8 billion (+7.3% YoY).
7%). net profit attributable to shareholders was ¥337 million (+28.6%).
7 billion with an equity ratio of 74.0%.
For the next fiscal year, the company forecasts 4 billion (+5.9%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms •Financial results — FY2025/12 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥10,766M | +7.3% |
| Operating profit | ¥343M | +7.7% |
| Net profit | ¥337M | +28.6% |
Next period forecast
Revenue
¥11,400M
+5.9%Op. profit
¥270M
-21.3%Net profit
¥220M
-34.7%Source: TDNet filing · Figures in millions of yen